Psychedelic medicine developer Cubed Biotech nabs C$3m financing
Toronto-based Cubed Biotech, a developer and maker of psychedelic medicine for the treatment of mental illness and addiction, has raised more than C$3 million in financing.
7 July 2021•2 mins read
